Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Not applicable Interventional Accepts healthy volunteers

Radicle Clarity: A Study of Health and Wellness Products on Mental Clarity and Health Outcomes

ClinicalTrials.gov ID: NCT05652725

Public ClinicalTrials.gov record NCT05652725. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jun 26, 2026, 3:31 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Radicle™ Clarity: A Randomized, Blinded, Placebo-Controlled Direct-to-Consumer Study of Health and Wellness Products on Cognitive Function and Other Health Outcomes

Study identification

NCT ID
NCT05652725
Recruitment status
Completed
Study type
Interventional
Phase
Not applicable
Lead sponsor
Radicle Science
Industry
Enrollment
4,826 participants

Conditions and interventions

Interventions

  • Clarity Active Study Product 1.1 Usage Dietary Supplement
  • Clarity Active Study Product 2.1 Usage Dietary Supplement
  • Clarity Active Study Product 3.1 Usage Dietary Supplement
  • Clarity Active Study Product 4.1 Usage Dietary Supplement
  • Clarity Active Study Product 4.2 Usage Dietary Supplement
  • Clarity Active Study Product 4.3 Usage Dietary Supplement
  • Placebo Control Form 1 Dietary Supplement
  • Placebo Control Form 2 Dietary Supplement
  • Placebo Control Form 3 Dietary Supplement
  • Placebo Control Form 4 Dietary Supplement
  • Placebo Control Form 5 Dietary Supplement
  • Clarity Active Study Product 5.1 Usage Dietary Supplement
  • Clarity Active Study Product 5.2 Usage Dietary Supplement

Dietary Supplement

Eligibility (public fields only)

Age range
21 Years to 105 Years
Sex
All
Healthy volunteers
Accepts healthy volunteers

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 8, 2023
Primary completion
Dec 11, 2023
Completion
Apr 23, 2024
Last update posted
May 19, 2024

2023 – 2024

United States locations

U.S. sites
1
U.S. states
1
U.S. cities
1
Facility City State ZIP Site status
Radicle Science, Inc Del Mar California 92014

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05652725, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 19, 2024 · Synced Jun 26, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT05652725 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →